Results 151 to 160 of about 25,109 (253)
Data from HER3 Is an Actionable Target in Advanced Prostate Cancer
, 2023 Veronica Gil, Susana Miranda, Ruth Riisnaes, Bora Gürel, Mariantonietta D’Ambrosio, Alessandro Vasciaveo, Mateus Crespo, Ana Ferreira, Daniela Brina, Martina Troiani, Adam Sharp, Beshara Sheehan, Rossitza Christova, George Seed, Ines Figueiredo, Maryou Lambros, David Dolling, Jan Rekowski, Abdullah Alajati, Matthew Clarke, Rita Pereira, Penny Flohr, Gemma Fowler, Gunther Boysen, Semini Sumanasuriya, Diletta Bianchini, Pasquale Rescigno, Caterina Aversa, Nina Tunariu, Christina Guo, Alec Paschalis, Cláudia Bertan, Lorenzo Buroni, Jian Ning, Suzanne Carreira, Paul Workman, Amanda Swain, Andrea Califano, Michael M. Shen, Andrea Alimonti, Antje Neeb, Jonathan Welti, Wei Yuan, Johann S. de Bono +43 moreopenalex +1 more sourceSupplementary Table S5 from Frequent Overexpression of HER3 in Brain Metastases from Breast and Lung Cancer
Erwin Tomasich, Ariane Steindl, Christina Paiato, Teresa Hatziioannou, Markus Kleinberger, Luzia Berchtold, Rainer Puhr, Johannes A. Hainfellner, Leonhard Müllauer, Georg Widhalm, Franziska Eckert, Rupert Bartsch, Gerwin Heller, Matthias Preusser, Anna Sophie Berghoff +14 moreopenalex +1 more sourceSupplementary Figure 5 from An Antibody That Locks HER3 in the Inactive Conformation Inhibits Tumor Growth Driven by HER2 or Neuregulin
, 2023 Andrew P. Garner, Carl Uli Bialucha, Elizabeth R. Sprague, Joan T. Garrett, Quan Z. Sheng, Sharon Li, Olga Sineshchekova, Parmita Saxena, Cammie R. Sutton, Dongshu Chen, Yan Chen, Huiqin Wang, Jinsheng Liang, Rita Das, Rebecca Mosher, Jian Gu, Alan Huang, Nicole Haubst, Carolin Zehetmeier, Manuela Haberl, Winfried Elis, Christian Künz, Analeah B. Heidt, Kara Herlihy, Joshua Murtie, Alwin G. Schuller, Carlos L. Arteaga, William R. Sellers, Seth A. Ettenberg +28 moreopenalex +1 more sourceDeterminants of long-term response to patritumab deruxtecan in breast cancer patient-derived xenografts. [PDF]
NPJ Precis OncolÒdena A, Monserrat L, Brasó-Maristany F, García-Galea E, Casals E, Molina C, Herencia-Ropero A, Pedretti F, Domènech H, Guzmán M, Rodríguez O, Grueso J, Esteve-Codina A, Dienstmann R, Chandarlapaty S, Fan PD, Suto F, Oliveira M, Prat A, Serra V. +19 moreeuropepmc +1 more sourceSupplemental Figure 1 from Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck Cancer
, 2023 Toni M. Brand, Stefan Hartmann, Neil E. Bhola, Hua Li, Yan Zeng, Rachel A. O’Keefe, Max V. Ranall, Sourav Bandyopadhyay, Margaret Soucheray, Nevan J. Krogan, Carolyn Kemp, Umamaheswar Duvvuri, Theresa LaVallee, Daniel E. Johnson, Michelle A. Ozbun, Julie E. Bauman, Jennifer R. Grandis +16 moreopenalex +1 more sourceData from The Anti-HER3 mAb Seribantumab Effectively Inhibits Growth of Patient-Derived and Isogenic Cell Line and Xenograft Models with Oncogenic <i>NRG1</i> Fusions
, 2023 Igor Odintsov, Allan J.W. Lui, Whitney J. Sisso, Eric Gladstone, Zebing Liu, Lukas Delasos, Renate I. Kurth, Exequiel M. Sisso, Morana Vojnic, Inna Khodos, Marissa S. Mattar, Elisa de Stanchina, Shawn M. Leland, Marc Ladanyi, Romel Somwar +14 moreopenalex +1 more source
